First Capital Advisors Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$845K Sell
5,103
-449
-8% -$72.5K 0.44% 57
2023
Q1
$861K Buy
5,552
+344
+7% +$55.5K 0.55% 51
2022
Q4
$920K Sell
5,208
-368
-7% -$63.5K 0.62% 49
2022
Q3
$911K Buy
5,576
+127
+2% +$21.5K 0.76% 39
2022
Q2
$967K Buy
+5,449
New +$971K 0.66% 37
2018
Q4
Sell
-1,496
Closed -$207K 162
2018
Q3
$207K Buy
+1,496
New +$199K 0.13% 160
2018
Q2
Sell
-1,295
Closed -$166K 476
2018
Q1
$166K Sell
1,295
-235
-15% -$31.8K 0.1% 183
2017
Q4
$214K Sell
1,530
-32
-2% -$4.46K 0.14% 162
2017
Q3
$203K Sell
1,562
-804
-34% -$107K 0.14% 150
2017
Q2
$313K Sell
2,366
-135
-5% -$17.2K 0.21% 114
2017
Q1
$311K Buy
+2,501
New +$299K 0.23% 110

Other funds holding JNJ

First Capital Advisors Group's JNJ Position: Q2 2023 in Review

First Capital Advisors Group reduced its Johnson & Johnson (JNJ) stake by 8.1% in Q2 2023, selling an estimated $72.5K and leaving 5,103 shares worth $845K. The position accounts for 0.44% of the portfolio, ranked #57.

First Capital Advisors Group first reported a position in JNJ in Q1 2017 and has held it in 11 quarters since. The position peaked at $967K in Q2 2022. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • First Capital Advisors Group held 5,103 shares of Johnson & Johnson worth $845K as of Q2 2023.
  • First Capital Advisors Group sold 449 Johnson & Johnson shares in Q2 2023, an estimated $72.5K.
  • Johnson & Johnson made up 0.44% of First Capital Advisors Group's portfolio in Q2 2023, its #57 holding.
  • First Capital Advisors Group first reported a position in Johnson & Johnson in Q1 2017 and has held it in 11 quarters since.
  • First Capital Advisors Group's Johnson & Johnson position peaked at $967K in Q2 2022.
  • 3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.